X. Tchiknavorian

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès, Marine Gilabert, E. François et al. · Annals of Oncology · 2012 · 213 citations · Full text

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +9

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

Thomas Bachelot, Thomas Filleron, Ivan Bièche et al. · Nature Medicine · 2021 · 152 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

Emmanuel Guardiola, Frédéric Peyrade, L. Chaigneau et al. · European Journal of Cancer · 2004 · 117 citations

Neck Cancer, Oncology, Nasopharyngeal Cancer +9

Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

Xavier Pivot, L. Cals, Didier Cupissol et al. · Oncology · 2000 · 36 citations

A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer

Jean-­Marc Ferrero, Cyril Foa, Simon Thézenas et al. · Oncology · 2004 · 31 citations